Department of Mathematics, Imperial College London, Huxley Building, 180 Queen's Gate, London SW7 2A7, UK.
Nature. 2011 Apr 21;472(7343):342-6. doi: 10.1038/nature09905. Epub 2011 Mar 27.
How is diversity maintained? Environmental heterogeneity is considered to be important, yet diversity in seemingly homogeneous environments is nonetheless observed. This, it is assumed, must either be owing to weak selection, mutational input or a fitness advantage to genotypes when rare. Here we demonstrate the possibility of a new general mechanism of stable diversity maintenance, one that stems from metabolic and physiological trade-offs. The model requires that such trade-offs translate into a fitness landscape in which the most fit has unfit near-mutational neighbours, and a lower fitness peak also exists that is more mutationally robust. The 'survival of the fittest' applies at low mutation rates, giving way to 'survival of the flattest' at high mutation rates. However, as a consequence of quasispecies-level negative frequency-dependent selection and differences in mutational robustness we observe a transition zone in which both fittest and flattest coexist. Although diversity maintenance is possible for simple organisms in simple environments, the more trade-offs there are, the wider the maintenance zone becomes. The principle may be applied to lineages within a species or species within a community, potentially explaining why competitive exclusion need not be observed in homogeneous environments. This principle predicts the enigmatic richness of metabolic strategies in clonal bacteria and questions the safety of lethal mutagenesis as an antimicrobial treatment.
多样性是如何维持的?环境异质性被认为是重要的,但在看似同质的环境中仍然观察到多样性。人们认为,这要么是由于选择较弱,要么是由于突变输入,要么是由于稀有基因型具有适应性优势。在这里,我们展示了一种新的稳定多样性维持的一般机制的可能性,这种机制源于代谢和生理权衡。该模型要求这种权衡转化为一种适合度景观,其中最适合的有不适合的近突变邻居,并且还存在一个更高的适合度峰值,具有更强的突变稳健性。“适者生存”适用于低突变率,而在高突变率下则适用于“最平坦者生存”。然而,由于准种水平的负频率相关选择和突变稳健性的差异,我们观察到一个过渡区,其中最适合和最平坦的共存。尽管简单环境中的简单生物可能维持多样性,但权衡越多,维持区就越宽。该原则可应用于物种内的谱系或群落内的物种,可能解释了为什么同质环境中不一定观察到竞争排斥。这一原则预测了克隆细菌中代谢策略的神秘丰富性,并质疑致死性诱变作为一种抗菌治疗的安全性。